Virax Biolabs Group Ltd VRAX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:21 AM EDT
7.31quote price arrow up+0.27 (+3.84%)
Volume
2,165
Close
7.04quote price arrow down-0.23 (-3.16%)
Volume
650,810
52 week range
5.40 - 29.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.04
  • 52 Week High29.00
  • 52 Week High Date07/29/22
  • 52 Week Low5.40
  • 52 Week Low Date07/29/22

Key Stats

  • Market Cap80.04M
  • Shares Out11.37M
  • 10 Day Average Volume8.95M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close7.04
  • 52 Week High29.00
  • 52 Week High Date07/29/22
  • 52 Week Low5.40
  • 52 Week Low Date07/29/22
  • Market Cap80.04M
  • Shares Out11.37M
  • 10 Day Average Volume8.95M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-0.06
  • P/E (TTM)-123.08
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-839,820.00
  • ROE (TTM)-
  • Revenue (TTM)110,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-781.62%
  • Debt To Equity (MRQ)-12.52%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Virax Biolabs Group Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Virax Biolabs Group Limited is a biotechnology company. The Company is primarily engaged in the sales, distribution and marketing of diagnostics test kits and med-tech and personal protective equipment (PPE) products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. It is developing a T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each...
Address
30 Broadwick Street
London
W1F 8LX
United Kingdom